• The ketogenic diet, which significantly restricts carbohydrates, shifts the body's primary energy source from glucose to ketones.
  • Some cancer cells prefer glucose (Warburg effect), so reducing blood glucose and insulin levels through ketosis may theoretically inhibit tumor growth.
  • IGF-1, a hormone that promotes cell proliferation, is linked to cancer risk. Ketogenic diets, with their moderate protein management, may help lower IGF-1 levels.
  • Chronic high blood sugar, type 2 diabetes, and obesity are risk factors for various cancers. Ketogenic diets can suppress post-meal blood sugar and insulin spikes, potentially reducing cancer risk indirectly.
  • While animal and cell studies show promise, human clinical trials are small-scale and yield mixed results depending on cancer type and treatment. It is not yet a substitute for standard treatment.
  • Self-administering extreme carbohydrate restriction during cancer treatment can be dangerous, potentially leading to malnutrition or worsening prognosis. Always consult your doctor and a nutritionist.

The ketogenic diet, which significantly restricts carbohydrates, has garnered attention for its potential role in cancer prevention and treatment. But what exactly is the scientific basis behind this? In this article, we will delve into the relationship between the ketogenic diet and cancer, based on the latest research and our own experiences.

What is the Ketogenic Diet?

The ketogenic diet is a dietary approach that drastically reduces carbohydrate intake (typically to 20-50g per day) and replaces it with fats. This shift forces the body to use fat as its primary energy source, producing ketone bodies (β-hydroxybutyrate, acetoacetate, acetone) from fatty acids in the liver. This state is known as ketosis.

Why is the Ketogenic Diet thought to be related to "cancer"?

"Warburg Effect" and Cancer Cells

Some cancer cells have a tendency to consume large amounts of glucose (the Warburg effect). Therefore, it is theoretically possible that high blood glucose and insulin levels could promote tumor growth. However, not all tumors have the same metabolic characteristics, and some have been reported to utilize ketone bodies.

IGF-1 (Insulin-like Growth Factor 1) and Protein Intake

IGF-1 is a hormone that promotes cell proliferation, and its association with cancer risk has been pointed out. Studies (such as those by Levine et al.) show that high protein intake tends to increase IGF-1, while low protein intake decreases it. Therefore, the "moderate protein management" in a ketogenic diet may play a role. However, extremely reducing protein can negatively affect muscle mass and immunity, so adjustments based on age and physical condition are necessary.

Association with High Blood Sugar, Type 2 Diabetes, and Obesity

Chronic high blood sugar and type 2 diabetes have been linked to an increased risk of colorectal, liver, and pancreatic cancers. The ketogenic diet significantly suppresses post-meal blood sugar and insulin spikes, suggesting it may indirectly affect cancer risk through glucose metabolism. Furthermore, obesity is a risk factor for multiple cancers, and the ketogenic diet's effectiveness as a weight-loss strategy is also promising.

Current Evidence and Limitations: Expectations and Cautions

Types of Research and Diversity of Results

While animal and cell studies report that ketogenic diets can suppress tumor growth, human clinical trials are small-scale, and results vary depending on the type of cancer and treatment status. The American Cancer Society and reviews from medical institutions (such as Ochsner Health) acknowledge its potential as an adjunct therapy but caution that "there is insufficient evidence to replace standard treatment."

Case-by-Case Judgment is Necessary

For some patients, the ketogenic diet can lead to calorie deficiency and weight loss (cachexia), which can worsen prognosis. Maintaining nutritional status is especially crucial during cancer treatment, and self-administering extreme carbohydrate restriction can be dangerous. Individuals using diabetes medications or insulin must manage the risk of hypoglycemia and ketoacidosis.

Practical Tips and Our Experience

  • Always consult your doctor and a nutritionist: During cancer treatment, collaboration with your medical team is paramount.
  • Adjust protein based on age and condition: While typical ketogenic diets have around 20% protein, some experts recommend lower protein for cancer prevention. Individualized approaches are necessary.
  • Ensure sufficient energy and micronutrients: Balancing vitamins, minerals, and unsaturated fatty acids is important.
  • Monitor regularly with tests: Check blood sugar, ketones, weight, and liver/kidney function.

From our short-term experience, we felt that blood sugar fluctuations stabilized, and our concentration improved in the mornings. However, this does not mean it "prevents cancer," so it should be approached with caution.

Summary

The ketogenic diet is suggested to influence cancer risk factors by suppressing blood sugar and insulin, and regulating IGF-1. However, there is no conclusive evidence that it is effective for all cancers, and for patients undergoing cancer treatment, there are risks such as nutritional deficiencies and interactions with treatment. It is most important to incorporate it safely, in consultation with your doctor and a nutritionist, based on individual circumstances. Our geefee team strives to provide information that values both scientific evidence and real-life experience.

Disclaimer: The information in this article is for general informational purposes only and does not constitute medical advice. Please consult a qualified healthcare professional before making any health-related decisions.